These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 7693282
1. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S. Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282 [Abstract] [Full Text] [Related]
2. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. Caccia S, Bizzi A, Coltro G, Fracasso C, Frittoli E, Mennini T, Garattini S. J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734 [Abstract] [Full Text] [Related]
3. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Gardier AM, Kaakkola S, Erfurth A, Wurtman RJ. Brain Res; 1992 Aug 14; 588(1):67-74. PubMed ID: 1382807 [Abstract] [Full Text] [Related]
4. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine. Caccia S, Confalonieri S, Bergami A, Fracasso C, Anelli M, Garattini S. Pharmacol Biochem Behav; 1997 Aug 14; 57(4):851-6. PubMed ID: 9259015 [Abstract] [Full Text] [Related]
5. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Garattini S, Bizzi A, Caccia S, Mennini T. Int J Obes Relat Metab Disord; 1992 Dec 14; 16 Suppl 3():S43-50. PubMed ID: 1338321 [Abstract] [Full Text] [Related]
6. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. Sánchez C, Hyttel J. Eur J Pharmacol; 1994 Nov 03; 264(3):241-7. PubMed ID: 7698161 [Abstract] [Full Text] [Related]
7. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. Rutter JJ, Auerbach SB. J Pharmacol Exp Ther; 1993 Jun 03; 265(3):1319-24. PubMed ID: 7685386 [Abstract] [Full Text] [Related]
8. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats. Durkin S, Prendergast A, Harkin A. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1894-901. PubMed ID: 18824064 [Abstract] [Full Text] [Related]
9. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI. Br J Pharmacol; 2001 Sep 12; 134(1):46-57. PubMed ID: 11522596 [Abstract] [Full Text] [Related]
10. Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Caccia S, Fracasso C, Garattini S, Guiso G, Sarati S. Neuropharmacology; 1992 Apr 12; 31(4):343-7. PubMed ID: 1381817 [Abstract] [Full Text] [Related]
11. Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55. Scheffel U, Kim S, Cline EJ, Kuhar MJ. Synapse; 1994 Apr 12; 16(4):263-8. PubMed ID: 8059336 [Abstract] [Full Text] [Related]
12. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Sánchez C, Meier E. Psychopharmacology (Berl); 1997 Feb 12; 129(3):197-205. PubMed ID: 9084057 [Abstract] [Full Text] [Related]
13. Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Simansky KJ, Vaidya AH. Brain Res Bull; 1990 Dec 12; 25(6):953-60. PubMed ID: 2149668 [Abstract] [Full Text] [Related]
14. Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. Faherty CJ, Earley B, Leonard BE. J Psychopharmacol; 1997 Dec 12; 11(1):53-8. PubMed ID: 9097894 [Abstract] [Full Text] [Related]
15. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Grimsley SR, Jann MW. Clin Pharm; 1992 Nov 12; 11(11):930-57. PubMed ID: 1464219 [Abstract] [Full Text] [Related]
16. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats. Bourdeaux R, Desor D, Lehr PR, Younos C, Capolaghi B. J Pharm Pharmacol; 1998 Dec 12; 50(12):1387-92. PubMed ID: 10052854 [Abstract] [Full Text] [Related]
18. Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat. Freo U, Merico A, Ermani M, Ori C. Neurosci Lett; 2008 May 09; 436(2):148-52. PubMed ID: 18387742 [Abstract] [Full Text] [Related]
19. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain. Hirano K, Maruyama S, Kimura R, Kagawa Y, Yamada S. Life Sci; 2004 Oct 29; 75(24):2933-45. PubMed ID: 15454344 [Abstract] [Full Text] [Related]
20. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat. Daniel WA, Syrek M, Haduch A, Wójcikowski J. J Pharm Pharmacol; 2001 Apr 29; 53(4):449-61. PubMed ID: 11341361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]